iFR与FFR指导PCI的5年结局比较
iFR-SWEDEHEART试验将2037例慢性或急性冠脉综合征患者随机分为iFR或FFR指导血运重建组,5年随访无失访。iFR组与FFR组主要复合终点(全因死亡、心肌梗死、非计划血运重建)发生率分别为21.5%与19.9%(HR 1.09,95%CI 0.90-1.33),各组分及预设亚组结果一致。
要点
- iFR指导血运重建的5年主要复合终点与FFR指导无差异。
- 全因死亡、非致死性心肌梗死和非计划血运重建率两组均无差异。
- 预设亚组间结果一致,支持iFR长期应用。
核心结论
- 在慢性或急性冠脉综合征患者中,iFR指导血运重建策略与FFR指导策略相比,5年死亡、心肌梗死和非计划血运重建复合终点无差异。
研究设计与样本
- iFR-SWEDEHEART为多中心、对照、开放标签、基于注册的随机临床试验,利用瑞典冠脉造影和血管成形术注册系统入组。
- 共2037例患者随机接受iFR或FFR指导的血运重建,5年随访无失访。
主要发现
- 5年主要复合终点发生率iFR组21.5%,FFR组19.9%(HR 1.09;95%CI 0.90-1.33)。
- 全因死亡iFR组9.4% vs FFR组7.9%(HR 1.20;95%CI 0.89-1.62)。
- 非致死性心肌梗死iFR组5.7% vs FFR组5.8%(HR 1.00;95%CI 0.70-1.44)。
- 非计划血运重建iFR组11.6% vs FFR组11.3%(HR 1.02;95%CI 0.79-1.32)。
- 预设亚组间结果一致。
临床怎么用
- 在慢性或急性冠脉综合征患者中,可考虑用iFR替代FFR指导血运重建,长期结局无差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Instantaneous wave-free ratio (iFR) is a coronary physiology index used to assess the severity of coronary artery stenosis to guide revascularization. iFR has previously demonstrated noninferior short-term outcome compared to fractional flow reserve (FFR), but data on longer-term outcome have been lacking. OBJECTIVES: The purpose of this study was to investigate the prespecified 5-year follow-up of the primary composite outcome of all-cause mortality, myocardial infarction, and unplanned revascularization of the iFR-SWEDEHEART trial comparing iFR vs FFR in patients with chronic and acute coronary syndromes. METHODS: iFR-SWEDEHEART was a multicenter, controlled, open-label, registry-based randomized clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enrollment. A total of 2,037 patients were randomized to undergo revascularization guided by iFR or FFR. RESULTS: No patients were lost to follow-up. At 5 years, the rate of the primary composite endpoint was 21.5% in the iFR group and 19.9% in the FFR group (HR: 1.09; 95% CI: 0.90-1.33). The rates of all-cause death (9.4% vs 7.9%; HR: 1.20; 95% CI: 0.89-1.62), nonfatal myocardial infarction (5.7% vs 5.8%; HR: 1.00; 95% CI: 0.70-1.44), and unplanned revascularization (11.6% vs 11.3%; HR: 1.02; 95% CI: 0.79-1.32) were also not different between the 2 groups. The outcomes were consistent across prespecified subgroups. CONCLUSIONS: In patients with chronic or acute coronary syndromes, an iFR-guided revascularization strategy was associated with no difference in the 5-year composite outcome of death, myocardial infarction, and unplanned revascularization compared with an FFR-guided revascularization strategy. (Evaluation of iFR vs FFR in Stable Angina or Acute Coronary Syndrome [iFR SWEDEHEART]; NCT02166736).
引用
- Götberg, Berntorp, Rylance, et al. 5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve. J Am Coll Cardiol. 2022. PMID: 35272801. doi:10.1016/j.jacc.2021.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。